Table 3.
Tumour type breakdown of cases reviewed by the Genomics Review Board
| Tumour type | Cases | % of total |
| Lung | 276 | 30.8 |
| Colorectal | 198 | 22.1 |
| Breast | 81 | 9.1 |
| Melanoma | 48 | 5.4 |
| Ovarian | 32 | 3.6 |
| Carcinoma of unknown primary | 31 | 3.5 |
| Not specified in clinical details | 27 | 3.0 |
| Cholangiocarcinoma | 27 | 3.0 |
| Pancreatic | 21 | 2.3 |
| Endometrial | 18 | 2.0 |
| Cervical | 13 | 1.5 |
| Bladder | 12 | 1.3 |
| Oesophageal | 11 | 1.2 |
| Gastric | 9 | 1.0 |
| Gastro-oesophageal junction | 7 | 0.8 |
| Anal | 6 | 0.7 |
| Renal | 6 | 0.7 |
| Gallbladder | 5 | 0.6 |
| Glioma | 5 | 0.6 |
| Oral | 5 | 0.6 |
| Prostate | 4 | 0.4 |
| Uterine | 4 | 0.4 |
| Hepatocellular | 3 | 0.3 |
| Leiomyosarcoma | 3 | 0.3 |
| Parotid | 3 | 0.3 |
| Salivary gland | 3 | 0.3 |
| Thymus | 3 | 0.3 |
| Ureter | 3 | 0.3 |
| Vulval | 3 | 0.3 |
| Appendiceal | 2 | 0.2 |
| Fallopian | 2 | 0.2 |
| Mesothelioma | 2 | 0.2 |
| Retroperitoneal sarcoma | 2 | 0.2 |
| Urachal carcinoma | 2 | 0.2 |
| Adrenal | 1 | 0.1 |
| Ampullary | 1 | 0.1 |
| Chondrosarcoma | 1 | 0.1 |
| Duodenal | 1 | 0.1 |
| Fibromyxosarcoma | 1 | 0.1 |
| Lacrimal gland | 1 | 0.1 |
| Myxofibrosarcoma | 1 | 0.1 |
| Nasopharynx | 1 | 0.1 |
| Optic nerve sheath | 1 | 0.1 |
| Osteoblastic chondrosarcoma | 1 | 0.1 |
| Osteosarcoma | 1 | 0.1 |
| Penile | 1 | 0.1 |
| Peripheral nerve sheath | 1 | 0.1 |
| Pneumocytoma | 1 | 0.1 |
| Kaposi sarcoma | 1 | 0.1 |
| Thyroid | 1 | 0.1 |
| Tracheal | 1 | 0.1 |
| Vaginal | 1 | 0.1 |